For patients diagnosed with diabetes, surgical procedures often raise concerns about wound healing and bone integration. Therefore, the question “I have diabetes—am I not suitable for osseointegration?” is quite common. While earlier approaches were more cautious, recent scientific evidence presents a clearer and more positive outlook for patients with well-controlled diabetes.
The Importance of Metabolic Control
The primary determinant for diabetic patients undergoing osseointegration is metabolic control. Specifically, maintaining an HbA1c below 8.5% and stable overall health allows the treatment to be planned safely. In patients with regulated blood glucose levels, bone–implant integration and healing can achieve outcomes very similar to those in non-diabetic individuals.
What Do Current Studies Show?
Clinical studies published in 2024 and 2025 indicate significant functional gains in diabetic patients following osseointegration. In one study, the proportion of patients able to use a prosthesis for more than 8 hours per day increased from 36% before surgery to 79% after osseointegration. Additionally, 94% of patients reported achieving a higher level of independence and activity in daily life.
Key Considerations During the Healing Process
Healing in diabetic patients requires closer monitoring. In some cases, minor additional surgical adjustments or more frequent dressing changes may be necessary to improve soft tissue integration. Furthermore, extra caution is essential to avoid falls or excessive mechanical load during the critical period of bone–implant integration.
Clinical Approach and Patient Follow-Up
Modern medicine does not consider diabetes an absolute contraindication for osseointegration. On the contrary, with a well-planned treatment, multidisciplinary follow-up, and regular metabolic control, successful outcomes are achievable. Close collaboration between the patient and healthcare team is critical for ensuring safety and long-term success.
Overall Assessment
In summary, a diagnosis of diabetes does not completely exclude patients from osseointegration therapy. With controlled diabetes, it is possible to enhance mobility, reduce socket-related problems, and improve quality of life. Careful patient selection, regular monitoring, and a structured approach allow this process to be safely managed.